Citius Pharmaceuticals Inc (CTXR)
0.6633
-0.02
(-3.10%)
USD |
NASDAQ |
May 08, 16:00
0.69
+0.03
(+4.03%)
After-Hours: 20:00
Citius Pharmaceuticals Price to Book Value: 1.245 for May 8, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 08, 2024 | 1.245 |
| May 07, 2024 | 1.285 |
| May 06, 2024 | 1.31 |
| May 03, 2024 | 1.324 |
| May 02, 2024 | 1.327 |
| May 01, 2024 | 1.364 |
| April 30, 2024 | 1.401 |
| April 29, 2024 | 1.299 |
| April 26, 2024 | 1.248 |
| April 25, 2024 | 1.376 |
| April 24, 2024 | 1.345 |
| April 23, 2024 | 1.441 |
| April 22, 2024 | 1.378 |
| April 19, 2024 | 1.416 |
| April 18, 2024 | 1.512 |
| April 17, 2024 | 1.532 |
| April 16, 2024 | 1.408 |
| April 15, 2024 | 1.437 |
| April 12, 2024 | 1.479 |
| April 11, 2024 | 1.564 |
| April 10, 2024 | 1.596 |
| April 09, 2024 | 1.672 |
| April 08, 2024 | 1.804 |
| April 05, 2024 | 1.876 |
| April 04, 2024 | 1.780 |
| Date | Value |
|---|---|
| April 03, 2024 | 1.812 |
| April 02, 2024 | 1.834 |
| April 01, 2024 | 1.934 |
| March 28, 2024 | 1.685 |
| March 27, 2024 | 1.547 |
| March 26, 2024 | 1.505 |
| March 25, 2024 | 1.506 |
| March 22, 2024 | 1.480 |
| March 21, 2024 | 1.409 |
| March 20, 2024 | 1.457 |
| March 19, 2024 | 1.395 |
| March 18, 2024 | 1.352 |
| March 15, 2024 | 1.383 |
| March 14, 2024 | 1.293 |
| March 13, 2024 | 1.352 |
| March 12, 2024 | 1.304 |
| March 11, 2024 | 1.352 |
| March 08, 2024 | 1.402 |
| March 07, 2024 | 1.401 |
| March 06, 2024 | 1.342 |
| March 05, 2024 | 1.373 |
| March 04, 2024 | 1.438 |
| March 01, 2024 | 1.460 |
| February 29, 2024 | 1.442 |
| February 28, 2024 | 1.475 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4475
Minimum
Dec 04 2019
11.68
Maximum
Feb 23 2021
1.851
Average
1.646
Median
Mar 07 2023
Price to Book Value Benchmarks
| QuidelOrtho Corp | 0.57 |
| TransCode Therapeutics Inc | 3.611 |
| NovaBay Pharmaceuticals Inc | 1.964 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.7198 |
Price to Book Value Related Metrics
| Price | 0.6633 |
| Earnings Yield | -39.20% |
| Market Cap | 105.53M |